Does BEVACIZUMAB Cause Metastasis? 225 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 225 reports of Metastasis have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.3% of all adverse event reports for BEVACIZUMAB.
225
Reports of Metastasis with BEVACIZUMAB
0.3%
of all BEVACIZUMAB reports
90
Deaths
40
Hospitalizations
How Dangerous Is Metastasis From BEVACIZUMAB?
Of the 225 reports, 90 (40.0%) resulted in death, 40 (17.8%) required hospitalization, and 11 (4.9%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
Yes, Metastasis is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
RITUXIMAB (191)
Which BEVACIZUMAB Alternatives Have Lower Metastasis Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ